Picture of Femasys logo

FEMY Femasys Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Femasys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.3-6.91-7.54-11.4-14.2
Depreciation
Amortisation
Non-Cash Items0.7210.744-0.2510.5591.26
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.080.558-0.733-0.4581.22
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-11-4.93-7.93-10.7-11.3
Capital Expenditures-0.697-0.032-0.307-0.407-0.144
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1310
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities12.30.968-0.307-0.407-0.144
Financing Cash Flow Items0-0.075-1.58-0.233-1.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.1280.87229.7-0.68220.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.18-3.0921.5-11.88.75